Human Subjects Subjects Clinical Trial Clinical Trial is question in any No, provide Error component to be marked as "Yes". PHS 398 Human N N Incl Multi Y For New and E The Human Subjects Cover Subjects NIH, 4.0 all Renewal Clinical Trial question Page Clinical CDC, and applications, if must be on the ‘No’ Trial FDA, Human Subjects Overall component, if (Y/N) AHRQ, Clinical Trial is the Human Subjects USU No on all Clinical Trial question components of is for all other the application ‘No’ and Human components in the Subjects Clinical application. Trial is Yes on the Overall, then provide Error. PHS 398 Human N N Multi Y For Revision and Answering to W ‘Yes’ Cover Subjects NIH, 4.0 all Resubmission Clinical Trial on the Page Clinical CDC, and applications, If Overall component Trial FDA, Clinical Trial is and to Clinical ‘No’ (Y/N) AHRQ, No on all Trial on all other USU components of components is the application typically not allowed and the Overall Clinical Trial is unless your Revision Yes, provide application (or Warning Resubmission of a Revision) does not include the components that involve Clinical Trial. PHS 398 Human N N Incl: Provide a Clinical Trials are not W Forms D, Cover Subjects NIH, 4.0 S10 warning if Human typically allowed for March Page Clinical CDC, and Subjects Clinical this type of funding 2016 Trial FDA, Trial is mark opportunity Release (Y/N) announcement. ‘Yes’.
Human Subjects Clinical Trial is No, provide Error Subjects Clinical Trial question in any component to be marked as "Yes". PHS 398 Cover Page Human Subjects Clinical Trial (Y/N) N N Incl NIH, CDC, FDA, AHRQ, USU 4.0 and Multi Y For New and Renewal applications, if Human Subjects Clinical Trial is No on all components of the application and Human Subjects Clinical Trial is Yes on the Overall, then provide Error. The Human Subjects Clinical Trial question must be ‘No’ on the Overall component, if the Human Subjects Clinical Trial question is ‘No’ for all other components in the application. E PHS 398 Cover Page Human Subjects Clinical Trial (Y/N) N N NIH, CDC, FDA, AHRQ, USU 4.0 and Multi Y For Revision and Resubmission applications, If Clinical Trial is No on all components of the application and the Overall Clinical Trial is Yes, provide Warning Answering ‘Yes’ to Clinical Trial on the Overall component and ‘No’ to Clinical Trial on all other components is typically not allowed unless your Revision application (or Resubmission of a Revision) does not include the components that involve Clinical Trial. W PHS 398 Cover Page Human Subjects Clinical Trial (Y/N) N N NIH, CDC, FDA, 4.0 and Incl: S10 Provide a warning if Human Subjects Clinical Trial is mark ‘Yes’. Clinical Trials are not typically allowed for this type of funding opportunity announcement. W Forms D, March 2016 Release all all
eSub-validations-draft-08-21-2017.docx